Click here to download Preliminary List of Scientific Presentations as a pdf.
(updated May 16, 2014)
Preliminary List of Scientific Presentations
(arranged alphabetically according to invited speaker)
Management Strategies of Combined Severe Symptomatic Carotid & Coronary Artery Disease
Mazen S. Abu-Fadel, University of Oklahoma HScC, Oklahoma City, OK, USA
Aldosterone Antagonists in Heart Failure: Clinical Settings and Timing
Chris Adamopoulos, Thessaloniki, Greece
Novel Alternative Mechanisms of Cardiovascular Calcification
Elena Aikawa, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA
Notch Signaling Promote Macrophage Activation and Vascular Diseases
Masanori Aikawa, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Atrial Fibrillation and Its Role in Cognitive Decline
Kannayiram Alagiakrishnan, University of Alberta, Edmonton, Alberta, Canada
Risk Factors for Cardiovascular Disease in Patients with Chronic Kidney Disease
Martin A. Alpert, University of Missouri- Columbia School of Medicine, Columbia, MO, USA
Heart Failure Related to Constrictive and Restrictive Cardiomyopathy: Assessment by Echocardiography
Aman M. Amanullah, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA
Gi Proteins, Natriuretic Peptide Receptor C and Regulation of Blood Pressure
Madhu B. Anand-Srivastava, University of Montreal, Montreal, Quebec, Canada
Pericardial Involvement Frequently Complicating Pulmonary and/or Systemic SarcoidGranulomatosis.A Life-Long, Multi Stage Disease, Periodical Study in 278 Biopsy –Proven Sarcoidosis Patients
Nestor Angomachalelis, G. Papanikolaou General Hospital, Thessaloniki, Greece
Left Atrial Dysfunction and Its Sequelae
Vignendra Ariyarajah, Bergen Cardiac Care Centre, Winnipeg, Canada
2014 Update on Management of Hypertension
Wilbert S. Aronow, New York Medical College, Valhalla, NY, USA
Prevalence and Clinical Implications of Nighttime Hypertension
Diana E. Ayala, Campus Universitario, Vigo, Pontevedra, Spain
Molecular Targeting of DCM
Balwan tTuana, University of Ottawa Heart Institute, Ottawa, Canada
Optimal Blood Pressure Levels in the Elderly? Results of REGARDS Study. Should We Correct The Guidelines?
Maciej Banach, Medical University of Lodz, Poland
Looking Back on the Look AHEAD Trial
Elizabeth Barrett-Connor, University of California San Diego, La Jolla, CA, USA
Managing Angina and Risk via Improved Endothelial Function: The EECP Model
Gregory Barsness, Mayo Clinic, Rochester, MN, USA
LDL Carbamylation in Chronic Uremia: Is There a Role for Myeloid Peroxidase?
Alexei G. Basnakian, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Stem Cell-Derived Megakaryocytes: Towards Understanding Genetic Control of Platelet Function
Lewis C. Becker, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Genetic Factors Influencing Carotid Artery Size in American Indians
Jonathan N. Bella, Bronx-Lebanon Hospital Center, Bronx, NY, USA
Present and Future of Nuclear Cardiology and Cardiac Ct in Cad: Value-Based Imaging
Daniel S. Berman, Cedars Sinai Medical Center, Los Angeles, CA
Renal Denervation in 2014
Stefan Bertog, Minneapolis VA Medical Center, MN, USA
Interventional Electrophysiology in Patients with Complex Congenital Heart Disease
Charles I. Berul, Children's National Medical Center, George Washington University, Washington, DC, USA
Twenty Year of C-Reactive Protein in Cardiology: Still an Appealing Marker of Disease?
Luigi M. Biasucci, Policlinico A. Gemelli, Catholic University of the Sacred Heart, Rome, Italy
Serendipity in Medicine; Does Chance Truly Favor the Prepared Mind?
Robert W.W. Biederman, Carnegie Mellon University, Allegheny General Hospital, Pittsburgh, PA, USA
Pleiotropic Effects of Ticagrelor, Potential Interaction with Aspirin
Yochai Birnbaum, Baylor College of Medicine, Houston, TX, USA
Impact of Coronary CT Angiography on Patient Management and Cardiovascular Outcomes: How to Integrate Test Results in Patient Care
Ron Blankstein, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
HDL Hypothesis: Where Do We stand Now?
William E. Boden, Samuel S. Stratton VA Medical Center, Albany, NY, USA
Prognostic Role of CMR in STEMI
Vicente Bodi, Hospital Clinico y Universitario de Valencia, University of Valencia,
Valencia, Spain
Renal Denervation in Heart Failure and Associated Co-Morbidities
Andreas Bollmann, Leipzig Heart Center, Leipzig, Germany
Public Reporting of Cardiac Interventional and Surgical Outcomes
William Bommer, University of California Davis, Davis, CA, USA
Aortic Regurgitation: Impact of Preoperative Symptoms for Post-Valve Replacement Survival on Prognostication from Myocardial Contractility
Jeffrey S. Borer, State University of New York Downstate Medical Center, New York,
NY, USA
Next Generation Sequencing Analysis of Families with Congenital Heart Disease
Neil E. Bowles, University of Utah School of Medicine, Salt Lake City, UT, USA
The Evolution of Antiplatelet Therapy for ACS - From Bench to Bedside
Sorin J. Brener, NY Methodist Hospital, NY, USA
Cenderitide: A Novel Designer Natriuretic Peptide for Post Acute Heart Failure
John C. Burnett Jr., Mayo Clinic, Rochester, MN, USA
Transcatheter Pulmonary Valve Implantation: Where Are We?
Gianfranco Butera, IstitutoPoliclinico San Donato, San Donato Milanese, Italy
Successful EVAR Program in a Rural Hospital
Samuel M. Butman, University of Arizona, Cottonwood, AZ, USA
Novel Mechanisms of Diabetic Vascular Oxidative Stress and Dysfunction
Hua Linda Cai, David Geffen School of Medicine, University of California Los Angeles, CA, USA
Prediction of Arrhythmic Events with Positron Emission Tomography
Michael E. Cain, University at Buffalo, Buffalo, NY, USA
The Role of Progenitor Cells in Atherosclerosis
Noel M. Caplice, University College Cork, Cork. Ireland
Sleep Apnea In Patients With CRT: Is It Worthwhile To Check?
Alessandro Capucci, UniversitàPolitecnicadelle Marche, Ancona, Italy
Low Gradient Severe Aortic Stenosis: Diagnosis and Management
Hari P. Chaliki, Mayo Clinic, Arizona, USA
Cardiovascular Risk Factors and Endothelial Dysfunction
Changyi (Johnny) Chen, Baylor College of Medicine, Houston, TX, USA
Dual Utilization of Exercise Echocardiograms and Myocardial Perfusion in Assessing Ischemia in a Cardiology Practice
Yzhar Charuzi, Cedars Sinai Heart Institute, Los Angeles, CA, USA
Transcatheter Aortic Valve Replacement: A Technology Coming Of Age
Asim N. Cheema, St. Michael's Hospital, Toronto, Canada
Dynamic LVOT Obstruction -Beyond HCM
Anand Chockalingam, University of Missouri, Columbia, MO, USA
Cysteine Protease Cathepsin K Controls Injury-induced Vascular Repair in Mice
Xian Wu Cheng, Nagoya University Graduate School of Medicine, Nagoya Japan
Peripheral Abnormalities in Heart Failure and Preserved Ejection Fraction
Julio A. Chirinos, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
The Role of Exercise and Rehabilitation for Heart Failure Patients
Christina Chrysohoou, Hippokration Hospital,University of Athens, Greece
The Controversies of Statin Therapy: An Overview and Assessment of the Data
Shorena Chumburidze, David Tvildiani Medical University, Tbilisi, Rep. of Georgia
Diagnostic and Prognostic Role of Noninvasive Coronary Flow Reserve
Quirino Ciampi, Fatebenefratelli Hospital, Pisa, Italy
Prevention of Sudden Cardiac Death during Sports: The Power of Pre-Participation Screening
Domenico Corrado, University of Padua Medical School, Padova, Italy
Advances in Heart Failure Treatment: Percutaneous Ventricle Restoration
Marco A. Costa, University Hospitals Case Medical Center, Cleveland, OH, USA
Mechanisms of Acute Coronary Syndromes: A Reappraisal
Filippo Crea, Catholic University, Rome, Italy
Clinical Effectiveness of CRT and ICD Therapy in Patients with Heart Failure by Race and Gender: Findings from IMPROVE HF
Anne B. Curtis, University at Buffalo, Buffalo, NY, USA
Patients with Different Etiology of Left Ventricular Failure Who, Moreover, Present Very Large Difference in the Level of Amyloid A
Sergio Dalla Volta, University of Padua Medical School, Padua, Italy
Dual AT1 Receptor/Neprilysin Inhibition ('ARNI') in Hypertension: An Improvement Versus AT1 Receptor Blockade?
Alexander H.J. Danser, Erasmus Medical Center, Rotterdam, The Netherlands
Arrhythmia Mechanisms in Arrhythmogenic Cardiomyopathy: Life Nanometers away from Sudden Death
Mario Delmar, New York University School of Medicine, York, NY, USA
Silent Cerebral Lesions Associated With Atrial Fibrillation Ablation
Thomas Deneke, University of Bochum, Germany
Genetics of Diastolic Heart Failure
Alan Y. Deng, Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada
Potential Therapy for the Prevention of Sudden Cardiac Death
Naranjan S. Dhalla, St. Boniface General Hospital Research Centre, University of Mantioba, Winnipeg, Canada
Alternate Healthy Eating Index, Mediterranean and Dash Dietary Patterns and Risk of Death in the Physician's Health Study
Luc Djousse, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Surgical Options in Heart Failure in the Elderly
Roland Hetzer, German Heart Institute, Berlin, Germany
Rescue of Physiologic Vascular Repair by Caspase-Inhibition: A Novel Approach to Better Treat Advanced Atherosclerosis
Randolph Hutter, Mount Sinai Medical Center, New York, NY, USA
Mitochondrial Dysfunction and Arrhythmic Risk: Possible New Therapies for Sudden Death
Samuel C. Dudley, University of Illinois at Chicago, Chicago, IL, USA
Radiation Doses and Best Practice Use in Nuclear Cardiology across the Globe: Findings from the 66 Country INCAPS Study
Andrew J. Einstein, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, USA
Guilt by Association: A Paradigm for Identifying a Silent Killer (Thoracic Aortic Aneurysm)
John A. Elefteriades, Yale University School of Medicine, New Haven, CT, USA
Functional and Anatomical Cardiac Imaging in Patients with Coronary Artery Stents
Abdou Elhendy, Marshfield Clinic, Marshfield, WI, USA
The Influenza Vaccine- Preventing Cardiovascular Events in High-Risk Patients
Michael Farkouh, Toronto General Hospital, Toronto, ON, Canada
Culprit vs Multivessel PCI in STEMI: What is best?
David P. Faxon, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA
Regression of Hypertrophy (and Fibrosis?) in Hypertrophic Cardiomyopathy
Michael A. Fifer, Massachusetts General Hospital, Boston, MA, USA
Toll-Like Receptor 9 Regulation of Coagulation in Acute Coronary Artery Disease
Janos G. Filep, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
New Insights in Masked Hypertension
Stanley S. Franklin, University of California, Irvine, CA, USA
A Case of Orthostatic Hypotension and Recent Advances
Gordon L. Fung, UCSF Medical Center at Mt. Zion, San Francisco, CA, USA
Association of Adverse Left Ventricular Remodeling with Incident Heart Failure and Ventricular Arrhythmias
William H. Gaasch, Lahey Clinic, Burlington, MA, USA
Molecular Drivers of Vascular Remodeling
ZorinaGalis, Division of Cardiovascular Sciences, NIH, Bethesda, MD, USA
Post-Ischemic Myocardial Insulin Resistance and Ischemic Heart Failure: Role of Mitochondria-ROS Uncoupling
Feng Gao, The Fourth Military Medical University, Xi'an, China
Fractional Flow Reserve
Joel Garcia, Denver Health Medical Center, Denver, CO, USA
Management of Stable Ischemic Heart Disease: Overview of Recent Guidelines
Julius M. Gardin, Hackensack University Medical Center, NJ, USA
Stem Cell Therapy for Cardiovascular Disease
Jon C. George, Temple University School of Medicine, Philadelphia, PA, USA
Translating T3 Treatment of Heart Failure From Bench to Bedside: Finally, A Safe Treatment/Monitoring Protocol that Should Work!
A. Martin Gerdes, New York Institute of Technology, Old Westbury, NY, USA
Contradictory Effects of Hyperlipidemia and Diabetes Mellitus on Progression of Abdominal Aortic Aneurysm: Pathobiological Mechanisms
S. David Gertz, The Hebrew University of Jerusalem, Jerusalem, Israel
The Short QT Syndrome and Sudden Cardiac Death
Michael H. Gollob, University of Ottawa Heart Institute, Ottawa, ON, Canada
Impaired Endogenous Thrombolysis- A Novel, Easy-To-Measure Biomarker of Adverse Cardiovascular Events
Diana A. Gorog, Imperial College, London, UK
Twenty-Five Years of Statins: Where Do We Go From Here?
Antonio M. Gotto, Jr., Weill Cornell Medical College, New York, NY, USA
Optimal Duration of Dual Antiplatelet Therapy after DES Implantation: EXCELLENT Trial and Future Perspectives
Hyeon-CheolGwon, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Synergistic Reduction of Atherosclerosis by the Combined LXR Ligand and ERK1/2 Inhibitor---A Multiple Mechanisms Dependent Pathway
Jihong Han, Nankai University, China
Can we Prevent Readmissions for Heart Failure?
Paul A. Heidenreich, Stanford University, Palo Alto, CA, USA
Statin Utilization: Emerging Clinical and Public Health Challenges
Charles H. Hennekens, Florida Atlantic University, Boca Raton, FL, USA
Sleep-Time Blood Pressure as a Therapeutic Target for Cardiovascular Risk Reduction
Ramon C. Hermida, Campus Universitario, Vigo, Pontevedra, Spain
Left Atrial Size and Function: Role in Prognosis
Brian D. Hoit, Case Western Reserve University, Cleveland, OH, USA
Evaluation of Neointimal Tissue after Drug-Eluting Stent Implantation with Optical Coherence Tomography
Myeong-Ki Hong, Severance Cardiovascular Center and Severance Biomedical Science Institute, Seoul, South Korea
Blood Pressure and the Risk of Cardiovascular Disease among Patientswith Type 2 Diabetes
Gang Hu, Pennington Biomedical Research Center, Baton Rouge, LA, USA
Genetics in Atrial Fibrillation: Impact for Improved Rhythm and Rate Control
Daniela Husser, University Leipzig Heart Center, Leipzig, Germany
Colchicine and New Management Strategies for Acute and Recurrent Pericarditis
Massimo Imazio, Maria Vittoria Hospital, Torino, Italy
Intravascular Near-Infrared Fluorescence Molecular Imaging of Inflamed Plaques
FaroucJaffer, Massachusetts General Hospital, Boston, MA, USA
Aldosterone, Copeptine and Other Neuroendocrine Markers in Patients with Stroke
Daniela Jezova, Slovak Academy of Sciences, Bratislava, Slovakia
Epigenetic Regulation of Laminar Flow-Mediated Genes and Atherosclerosis
Zheng-Gen Jin,University of Rochester School of Medicine and Dentistry, New York, USA
Disturbed Flow Induces Inflammation and Atherosclerosis by Decreasing TIMP3 - A Role for MechanosensitivemiRNA
Hanjoong Jo, Georgia Tech and Emory University, Atlanta, GA, USA
Aging and Heart Failure: 2014 Update
Bodh I. Jugdutt, University of Alberta and Hospitals, Edmonton, Alberta, Canada
Right Ventricular Failure after Implantation of Left Ventricular Assist Devices
Andreas Kalogeropoulos, Emory University School of Medicine, Atlanta, GA, USA
Fractional Flow Reserve (FFR) at 2014- Where are we and where is it Going?
Edo Kaluski, University Hospital, Newark, NJ, USA
HFpEF (Heart Failure with Preserved Ejection Fraction) Pathophysiology: Implications for Therapeutic Targets
David M. Kaye, Baker IDI Heart and Diabetes Institute, Alfred Hospital, Melbourne, Australia
Cardiorenal Syndrome: Not As Straight Forward As We Used to Think
Amir Kazory, University of Florida, Gainesville, FL, USA
Implications for the Use of Accelerometer Data in Patient Management
Ilan Kedan, Cedars Sinai Heart Institute, Beverly Hills, CA, USA
Body Mass Index and Mortality: Is Being Overweight Really Healthy?
Arthur L. Klatsky, Kaiser Permanente Medical Center, Oakland, CA, USA
The Effect of Bendavia on Ischemia/Reperfusion Injury, Left Ventricular Remodeling and Dysfunction
Robert A. Kloner,Good Samaritan Hospital/USC, Los Angeles, CA, USA, University of Southern California, Los Angeles, CA, USA
Innate Immunity and Heart Disease
Anne A. Knowlton, University of California, Davis, CA, USA
Non Pharmacological and Catheter Based Therapy of Difficult to Treat (D2T) Hypertension
Santhosh K.G. Koshy, UT Health Sciences Center, Memphis, TN, USA
Role of MicroRNA in Cardioprotection
Rakesh C. Kukreja, Virginia Commonwealth University, Richmond VA, USA
PCI versus CABG in Multiple Vessel CAD
Adarsh Kumar, Govt Medical College/GND Hospital, Amritsar, India
Clinical Implications of Silent Cerebral Embolization and Role of Neuro-Protection during Cardiac Procedures
Alexandra Lansky, Yale University School of Medicine, New Haven, CT, USA
Live Cell Superresolution Microscopy Identifies Proliferative Nanopathology of T-Tubule Membranes
Stephan E. Lehnart, University Medical Center Goettingen, Germany
New Avenues in the Fight against Atherosclerosis
Stephanie Lehoux, McGill University, Montreal, QC, Canada
Echocardiographic Insights: From Morphology to Mechanisms of Mitral Valve Disease and Beyond
Robert A. Levine, Massachusetts General Hospital, Boston, MA, USA
Metabolic Syndrome and Cardiovascular Disease
T. Barry Levine, Drexel University College of Medicine, Philadelphia, PA, USA
Mitochondrial Dysfunction and Diabetic Heart Disease
Qiangrong Liang, New York Institute of Technology, Old Westbury, NY, USA
Carbon Nanotubes Scaffolds as a New Basis for Cardiac Tissue Engineering
Carlin S. Long, University of Colorado Health Sciences Center, Denver Health Medical Center, Denver, CO, USA
FFR and Peripheral Disease
Amir S Lotfi, Tufts University School of Medicine, Baystate Medical Center, Springfield, MA, USA
Serpins as Therapy – from Virus to Man
Alexandra Lucas, University of Florida, Gainesville, FL, USA
The Pathway of Pericyte Cell Therapy in Cardiovascular Disease
Paolo Madeddu, University of Bristol, UK
Triggers of Acute Cardiovascular Events: Clinical Implications
Mohammad Madjid, Texas Heart Institute, Houston, TX, USA
Stress-Only Imaging; A New Paradigm for Performing Stress Myocardial Perfusion Imaging
John Mahmarian, Houston Methodist Debakey Heart And Vascular Center, Houston Texas
Precision Medicine for Today and Tomorrow: Targeting Molecular Pathways for Vascular Disease
Kenneth Maiese, University of Medicine & Dentistry of New Jersey, Newark, NJ, USA
Women and Heart Disease: Update on Prevention
Shaista Malik, UC Irvine, CA, USA
The Pivotal Role of L-Arginine in the Ischemic Heart Preconditioning - A Nanomedical Approach
Tadeusz Malinski, Ohio University, Athens, OH, USA
Temporal Variation in Acute Aortic Diseases: Only a Random Phenomenon?
Roberto Manfredini, University of Ferrara, Italy
Demographic Changes in Congenital Heart Disease in the XXI Century: Impact in Management and Outcomes
ArianeMarelli, Mc Gill University Health Centre, Montreal, QC, Canada
Training of Cardiovascular Physician-Scientists in the US: Results of Specific Training Pathways
James D. Marsh, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Prevention of Stroke in Atrial Fibrillation: Are All Oral Drugs the Same?
Antoni Martinez Rubio, Hosp. de Sabadell - Univ. Autonoma de Barcelona, Sabadell, Spain
Prolylhydroxylases in Ischemic Heart Disease
NilanjanaMaulik, University of Connecticut School of Medicine, Farmington, CT, USA
Saturated Fat Intake and the Genesis of Coronary Artery Disease – Where’s The Evidence?
Jawahar L. Mehta, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Stem Cell and Gene Therapy for Heart Failure
Leslie W. Miller, University of South Florida, Tampa, FL, USA
Integrative and Complementary Medicine in Cardiology: New Hope or Just Hip and Hype?
Freny Vaghaiwalla Mody, VA Greater Los Angeles HCS, CA, USA
Cardiac Surgery in the Adult Congenital Heart Disease Patient: A Spectrum of Lesions
Bassem Mora, Sheikh Khalifa Medical City, Cleveland Clinic, Abu Dhabi, United Arab Emirates
Residual Vascular Risk after Statin Therapy: The Promise of Novel Lipoprotein Biomarkers
Samia Mora, Brigham and Women's Hospital, Boston, MA, USA
Indoxyl Sulfate and Cardio-Renal Syndrome; The Role Of Aryl Hydrocarbon Receptor
Toshisuke Morita, Toho University Omori Medical Center, Ota-ku, Tokyo, Japan
Advancements in Telemedicine and Application in Specialty Practice
Alexander Morss, Harbor Medical Associates, Boston, MA, USA
Update on Coronary Bifurcation Classification and Techniques
Mohammad R. Movahed,The Southern Arizona VA Health Care System, Tucson, AZ, USA
Epidemiology and Risk Factors of Early Mortality after Heart Transplantation: A US National Perspective
Marjan Mujib, Westchester Medical Center at New York Medical College, Valhalla, NY, USA
Determinants of Cardiac Function in Patients with End Stage Dilated Cardiomyopathy
Sherif F. Nagueh, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA
Skeletal Muscle Hypertrophy Induced by Novel KAATSU Rehabilitation and Prevention of Sarcopenia
Toshiaki Nakajima, University of Tokyo, Tokyo, Japan
Biomarkers in Cardiac Allograft Vasculopathy
Nandini Nair, Sacred Heart Medical Center, Spokane, WA, USA
Echocardiography: Past, Present and Future
Navin C. Nanda, University of Alabama at Birmingham, Birmingham, AL, USA
Regulation of Intestinal Genes by an 18 Mer Peptide Reduces Systemic Inflammation and Improves Cardiovascular Status
Mohamad Navab, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
De-risking High Risk Asymptomatic Individuals by Coronary Artery Calcium Testing: Power of Zero!
Khurram Nasir, Baptist Health, Miami Beach, FL, USA
Regulation of EnosMrna Destabilization Via ROCK2-Mediated Eef1a1 Phosphorylation
Kensuke Noma, Hiroshima University Hospital, Hiroshima, Japan
Prognostic Value of Microvascular Obstruction on Multidetector Computed Tomography after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
Kenji Okumura, Toki Municipal General Hospital, Toki, Japan
Mechanisms of Hypertrophy in Valvular Heart Disease
NielsThue Olsen, Rigshospitalet, Copenhagen, Denmark
Intravascular Near-Infrared Fluorescence Molecular Imaging of Inflamed Plaques"
Eric A. Osborn, Massachusetts General Hospital, Boston, MA, USA
Mediterranean Diet and Secondary Prevention of CVD
Demosthenes B. Panagiotakos, Harokopio University, Athens, Greece
Genetic Disruption of Npr1 Upregulates Cardiac Expression of Proinflammatory MediatorsKailash N. Pandey, Tulane University School of Medicine, New Orleans, LA, USA
Management of Atrial Flutter
HakanPaydak, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Hand Held Echocardiography: Role in Clinical Practice
Patricia A. Pellikka, Mayo Clinic College of Medicine and Mayo Foundation, Rochester,
MN, USA
Introduction of a Mouse Model that Reflects Human Atherosclerotic Plaque Instability and Rupture: A Unique Tool for Discovery of Strategies towards Plaque Pacification and Ultimately Prevention of Myocardial Infarction
Karlheinz Peter, Baker IDI Heart and Diabetes Institute, Victoria, Australia
Myocardial Elasticity and Cardiac Function
Cristina Pislaru, Mayo Clinic College of Medicine, Rochester, MN, USA
A Tale Of Two Hearts: Any New Echocardiography Tricks in Valvular Heart Disease?
Sorin Pislaru, Mayo Clinic College of Medicine, Rochester, MN, USA
Hybrid Ablation of Atrial Fibrillation: Hype or Here to Stay?
Laurent Pison, Maastricht University Medical Center, Maastricht, The Netherlands
The Effect of Financial Crisis on the Health Status of Population...Insights from Greece
Christos Pitsavos, 1st Cardiology Clinic University of Athens, Athens, Greece
The Management of Patients with Advanced Heart Failure
Maria Vittoria H. Pitzalis, East Carolina University, The Brody School of Medicine, Greenville, NC, USA
Antihypertensive Effect of Flaxseed
Kailash Prasad, University of Saskatchewan, Saskatoon, SK, Canada
Biophysics of Myeloperoxidase Interactions with HDL: An Index of Functionality?
Kirkwood A. Pritchard Jr., Children's Research Institute, Milwaukee, WI, USA
Left Ventricular Function in Patients with Chronic Total Occlusion of LAD: Long-Term Follow-Up
Maria Prokudina, Federal Center of Heart, Blood and Endocrinology, St. Petersburg, Russia
Genetic Discovery of CVD in Diabetic Patients
Lu Qi, Harvard School of Public Health, Boston, MA, USA
Aspirin-Insensitive Thromboxane Generation; A Novel Risk Factor for Cardiovascular Disease
Jeffrey J. Rade, UMASS Medical School, Worcester, MA, USA
ACE2 as a Target for Cardio-Pulmonary Disease Therapeutics
Mohan K. Raizada, University of Florida, Gainesville, FL, USA
Atorvastatin Attenuates Atherosclerosis In The Valves And Femurs From HypercholesterolemicLdlr-/- Mice AS=OP
Nalini Rajamannan, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
The Macrophage A2b Adenosine Receptor Controls Tissue Insulin Sensitivity: Implications for Vascular Disease
Katya Ravid, Boston University School of Medicine, MA, USA
Atypical and Unusual Clinical Presentations of Patients with Ischemic Heart Disease
Hanumanth K. Reddy, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Translation of Genomic Discoveries for CAD
Muredach P. Reilly, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Translation of HDL Functionality into Clinical Practice
Robert S. Rosenson,Mount Sinai School of Medicine, New York, NY, USA
Effects of Long-Term Therapy with Bendavia (MTP-131), a Novel Mitochondria-Targeting Peptide, on Skeletal Muscle Fiber Type Composition in Dogs with Chronic Heart Failure
Hani N. Sabbah, Henry Ford Heart & Vascular Institute, Detroit, MI, USA
Is Ischemia Universal In A Chronic Total Occlusion?
Rajesh Sachdeva, Little Rock, AR, USA
Device Closure of Complex Atrial Septal Defect in Adults- Issues and Solutions
Masood Sadiq, The Children's Hospital/The Institute of Child Health, Lahore. Pakistan
Benefit and Risks of Antidiabetic Treatment in Patients with Coronary Artery Disease and Heart Failure
Christoph H. Saely, VIVIT Institute, Academic Teaching Hospital, Feldkirch, Austria
Mechanistic Insights Into Diastolic Heart Failure (Heart Failure [HF] Preserved Ejection Fraction) – What Progress Have We Made?
Flora Sam, Boston University School of Medicine, Boston, MA, USA
Pharmacological Modulation of Angiotensin-II-Induced Arterial Mononuclear Cell Adhesion by Nuclear Receptors Activation
Maria J. Sanz, Universidad de Valencia, Spain
Role of Minocycline in Myocardial Ischemia-Reperfusion Injury: An Old Drug with New Implications
Tiziano M. Scarabelli, St John Hospital & Medical Center/Wayne State University SOM, USA
High Sensitivity Cardiac Troponin – A Cardiologist's Friend or Foe?
Saul Schaefer, University of California, Davis, CA, USA
Heart Failure Management: New Technologies to Improve the Outcome in Cardiac Resynchcronization Therapy
Karlheinz Seidl,Klinikum Ingolstadt GmbH, Ingolstadt, Germany
Diabetes and Failed Regenerative Strategies
Frank W. Sellke, Alpert Medical School of Brown University, Providence, RI, USA
Do Vitamin and Mineral Supplements have a Role in Cardiovascular Disease Prevention?
Howard D. Sesso, Brigham and Women's Hospital, Boston, MA, USA
Evolving Role of Platelet Function Testing In Management of Acute Coronary Syndromes
Rakesh Sharma, University of Arkansas Medical Science, Little Rock, AR, USA
Regulatory T Cells in Abdominal Aortic Aneurysms
Guo-Ping Shi, Brigham and Women's Hospital, Boston, MA, USA
Imaging ACE and Angiotensin Receptors in the Heart
Jamshid Shirani, St. Luke's Hospital and Health Network, Bethlehem, PA, USA
The Future of Stable Ischemic Heart Disease and The ISCHEMIA Trial
Mandeep S. Sidhu, Albany Medical Center, Albany, NY, USA
Is the DASH Diet the Optimal Diet for Heart Failure Patients?
Marc A. Silver, Advocate Christ Medical Center, University of Illinois. IL, USA
Inflammation and Post-Ischemic Cardiac Remodeling: Molecular Mechanisms and Therapeutic Perspectives
Jean-Sebastian Silvestre, Paris-Centre de RechercheCardiovasculaire, Paris, France
The Interactive Role of Cytokines in Cardiomyocyte Survival
Pawan K. Singal, St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada
Inflammation Induced Apoptosis in the Injured Myocardium
Dinender K. Singla, University of Central Florida, Orlando, FL, USA
Comparison of Cost-effectiveness of Direct Current Cardioversion, Transesophageal pacing and Digoxin in the Conversion of Atrial Flutter in the Neonate
Christopher S. Snyder, Rainbow Babies and Children's Hospital, Cleveland, OH, USA
Heart Failure with Preserved Ejection Fraction: A Misunderstood Syndrome in Search of a Therapy
Scott D. Solomon, Brigham and Women's Hospital, Boston, MA, USA
Racial Differences in Vitamin D/Parathyroid Hormone Endocrine System
Yiqing Song, Indiana University, Indianapolis, IN, USA
Cardiac Magnetic Resonance Imaging for Coronary Artery Disease
Fabiola Sozzi, Ospedale Maggiore Policlinico, Italy
Time to Focus on CV Health (Not CV Disease)
Laurence Sperling, Emory University School of Medicine, Atlanta, GA, USA
Role of Endothelin-1 and Camkinase Ii Signaling in Cardiovascular Complications
Ashok K. Srivastava, CRCHUM, University of Montreal, Montreal, Quebec, Canada
Ablation of Idiopathic Ventricular Tachycardia
Komandoor Srivathsan, Mayo Clinic, Arizona, USA
In-vivo Risk Stratification of Individual Coronary Artery Plaques: An Evolving Paradigm for Pre-emptive Management of Patients with Coronary Artery Disease
Peter H. Stone, Harvard Medical School, Brigham & Women's Hospital, Boston, MA, USA
Temporal Trends in Valvular Heart Disease in New York State: The Last 30 Years
Phyllis G. Supino, State University of New York (SUNY) Downstate Medical Center, NY, USA
Non-invasive Risk Stratification in Brugada Syndrome without History of Cardiac Arrest: Prognostic Value of J-wave and ST-segment Morphology
Masahiko Takagi, Osaka City University Graduate School of Medicine, Osaka, Japan
Vascular Healing &Bioresorbable Scaffolds: From Platelets, Leukocytes to Endothelial Cells
Jean-François Tanguay, Université de Montréal, Canada
Association between Obstructive Sleep Apnea and Coronary Artery Disease
Akira Tamura, Oita University, Yufu, Japan
PET/CT & PET/MR Imaging of Atherosclerosis
Ahmed Tawakol, Massachusetts General Hospital, Boston, MA, USA
Old and Emerging Options for Treatment of Refractory Angina: A Critical Appraisal
UdhoThadani, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, OK, USA
PolyvascularDisease:Vascular Function, Imaging and Treatment
TakanobuTomaru, Toho University, Japan
Molecular Targets in Dilated Cardiomyopathy
BalwantTuana. University of Ottawa, Ottawa, ON, Canada
Mitochondrial Division/Mitophagy Inhibitor (Mdivi) Ameliorates Pressure Overload Induced Heart Failure
Suresh C. Tyagi,University of Louisville School of Medicine, Louisville, KY, USA
Risk Stratification of Very Late DES Failure by the Evaluation of Neoatherosclerosis
Yasunori Ueda, Osaka Police Hospital, Osaka University Graduate School of Medicine, Japan
The Treatment of the Chronic Total Occlusion
Barry F. Uretsky, University of Arkansas for Medical Sciences, Little Rock, AR, USZ
Role of Oxidative Protein Modifications in Regulating Kinase Pathways in Heart Failure: Role in Therapy
Jennifer Van Eyk, Johns Hopkins University, Baltimore, MD, USA
Imatinib: A Novel Candidate for Treatment of Permeability Edema
Geerten P. van Nieuw Amerongen, VU University Medical Center, Amsterdam,
The Netherlands
Pericutaneous Hemodynamic Support for High Risk PCI: Indications and Results
George W. Vetrovec, VCU Medical Center Richmond, VA, USA
Thromboembolism or Athero-thromboembolism in Atrial Fibrillation?
Francesco Violi, University of Rome, Italy
Dietary Fatty Acid Composition as a Risk Factor for Cardiometabolic Disorders: Beyond the Calories
Lu Wang, Brigham and Women's Hospital, Boston, MA, USA
Molecular and Structural Remodeling Underlying the Defective Cell Contractility in Heart Failure
Shi-Qiang Wang, Peking University, Beijing, China
Priming the Proteasome by PKG: A Novel Cardioprotective Mechanism of Sildenafil
Xuejun Wang, Sanford School of Medicine of the University of South Dakota, Vermillion,
SD, USA
Gender Disparity in Coronary Heart Disease: Bias, Biology, or Both?
Nanette K. Wenger, Emory University School of Medicine, Atlanta, GA, USA
New Guidelines on Cardiovascular Risk Assessment
Nathan D. Wong, University of California, Irvine, CA, USA
The Genetics of Aortic Dissection
Angela T. Yetman, University of Utah, Salt Lake City, UT, USA
De Novo Regulatory Pathway of Niche on Stem Cells in Cardiac Remodeling
Xi-Yong Yu, Guangdong Academy of Medical Sciences, Guangzhou, China
Improving Energy Supply to Mend a Sick Heart
Qinglin Yang, University of Alabama at Birmingham, Birmingham, AL, USA
Cilia and Congenital Heart Disease: What is the Connection?
Maliha Zahid, University of Pittsburgh, Pittsburgh, PA, USA
Integrating Nutrition into the Cardiovascular Curriculum Changes Medical Student Eating Habits
Robert Zelis, Pennsylvania State University, Hershey Medical Center, Hershey, PA, USA
Discovery of a New Index of Dual Pathway Atrioventricular Node Conduction
Youhua Zhang, New York Institute of Technology (NYIT) College of Osteopathic Medicine,
Old Westbury, NY, USA
